AMRN: Amarin Corporation plc – Depositary Receipt (Common Stock) Stock

by  •  • Comments Off on AMRN: Amarin Corporation plc – Depositary Receipt (Common Stock) Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 552.10
Book Value / Share 1.34
Price / Book n/a
NCAV ($M) 445.39
NCAV / Share 1.08
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.11
Return on Assets (ROA) -0.07
Return on Equity (ROE) -0.10

Liquidity (mrq)
Quick Ratio 1.80
Current Ratio 2.80

Balance Sheet (mrq) ($M)
Current Assets 724.98
Assets 831.68
Liabilities 279.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 306.91
Operating Income -17.39
Net Income -59.11
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 6.88
Cash from Investing -25.52
Cash from Financing 0.23

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
12-08 13G/A Morgan Stanley 1.60 -70.85
12-05 13D/A Sarissa Capital Management LP 8.20 14.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-01 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2022 OR ☐ TRANSITION

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 193,724 643,829 30.09
2024-04-23 156,485 749,965 20.87
2024-04-22 258,588 720,877 35.87
2024-04-19 313,455 222,586 140.82

(click for more detail)

Similar Companies
ACAB – Atlantic Coastal Acquisition Corp. II ACET – Adicet Bio, Inc.
ACIU – AC Immune SA ACRV – Acrivon Therapeutics, Inc.
ADMA – ADMA Biologics, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Amarin Corp